Company / Cost of Revenue
Lunai Bioworks Inc. Cost of Revenue History
FY2014-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$5.3K
FY2017
5-year range
$5.3K / $295.7K
FY2014-FY2017
Trend
-98.2%
vs FY2016
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $109,299 to $5,275 over the past 3 years.
Based on SEC 10-K filings.
$5,275 in FY2017.
Improved from $109,299 to $5,275 over the past 3 years.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- -63.6%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -63.6%, indicating a declining trend.
- In FY2017, cost of revenue decreased 98.2% year-over-year.
Company context
Key Data Points
- Altman Z-Score -1.04 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2017 | $5.3K | -98.2% |
| FY2016 | $295.7K | +170.5% |
| FY2014 | $109.3K | - |
| FY2011 | - | - |
As of FY2017 · SEC 10-K · Updated Jun 24, 2026